1024P Initial clinical results of BT-001, an oncolytic virus expressing an anti-CTLA4 mAb, administered as single agent and in combination with pembrolizumab in patients with advanced solid tumors.
Saved in:
| Title: | 1024P Initial clinical results of BT-001, an oncolytic virus expressing an anti-CTLA4 mAb, administered as single agent and in combination with pembrolizumab in patients with advanced solid tumors. |
|---|---|
| Authors: | Champiat, S.1 (AUTHOR), Lebbe, C.2 (AUTHOR), Baurain, J-F.3 (AUTHOR), Italiano, A.4 (AUTHOR), Sakkal, M.5 (AUTHOR), Spring-Giusti, C.6 (AUTHOR), Stojkowitz, N.6 (AUTHOR), Brandely, M.6 (AUTHOR), Sadoun, A.6 (AUTHOR), Ropenga, A.7 (AUTHOR), Semmrich, M.7 (AUTHOR), McAllister, A.7 (AUTHOR), Chisamore, M.8 (AUTHOR), Cassier, P.9 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS692-S692. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1083 |
